Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: A study in male mice

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome : A study in male mice. / Didriksen, Michael; Fejgin, Kim; Nilsson, Simon R O; Birknow, Michelle Rosgaard; Grayton, Hannah M.; Larsen, Peter H.; Lauridsen, Jes B.; Nielsen, Vibeke; Celada, Pau; Santana, Noemi; Kallunki, Pekka; Christensen, Kenneth V; Werge, Thomas M.; Stensbøl, Tine B.; Egebjerg, Jan; Gastambide, Francois; Artigas, Francesc; Bastlund, Jesper F.; Nielsen, Jacob.

I: Journal of Psychiatry and Neuroscience, Bind 42, Nr. 1, 2017, s. 48-58.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Didriksen, M, Fejgin, K, Nilsson, SRO, Birknow, MR, Grayton, HM, Larsen, PH, Lauridsen, JB, Nielsen, V, Celada, P, Santana, N, Kallunki, P, Christensen, KV, Werge, TM, Stensbøl, TB, Egebjerg, J, Gastambide, F, Artigas, F, Bastlund, JF & Nielsen, J 2017, 'Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: A study in male mice', Journal of Psychiatry and Neuroscience, bind 42, nr. 1, s. 48-58. https://doi.org/10.1503/jpn.150381

APA

Didriksen, M., Fejgin, K., Nilsson, S. R. O., Birknow, M. R., Grayton, H. M., Larsen, P. H., Lauridsen, J. B., Nielsen, V., Celada, P., Santana, N., Kallunki, P., Christensen, K. V., Werge, T. M., Stensbøl, T. B., Egebjerg, J., Gastambide, F., Artigas, F., Bastlund, J. F., & Nielsen, J. (2017). Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: A study in male mice. Journal of Psychiatry and Neuroscience, 42(1), 48-58. https://doi.org/10.1503/jpn.150381

Vancouver

Didriksen M, Fejgin K, Nilsson SRO, Birknow MR, Grayton HM, Larsen PH o.a. Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: A study in male mice. Journal of Psychiatry and Neuroscience. 2017;42(1):48-58. https://doi.org/10.1503/jpn.150381

Author

Didriksen, Michael ; Fejgin, Kim ; Nilsson, Simon R O ; Birknow, Michelle Rosgaard ; Grayton, Hannah M. ; Larsen, Peter H. ; Lauridsen, Jes B. ; Nielsen, Vibeke ; Celada, Pau ; Santana, Noemi ; Kallunki, Pekka ; Christensen, Kenneth V ; Werge, Thomas M. ; Stensbøl, Tine B. ; Egebjerg, Jan ; Gastambide, Francois ; Artigas, Francesc ; Bastlund, Jesper F. ; Nielsen, Jacob. / Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome : A study in male mice. I: Journal of Psychiatry and Neuroscience. 2017 ; Bind 42, Nr. 1. s. 48-58.

Bibtex

@article{28f59972157843afa2b5de1ae31ba1ee,
title = "Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: A study in male mice",
abstract = "Background: The hemizygous 22q11.2 microdeletion is a common copy number variant in humans. The deletion confers high risk for neurodevelopmental disorders, including autism and schizophrenia. Up to 41% of deletion carriers experience psychotic symptoms. Methods: We present a new mouse model (Df(h22q11)/+) of the deletion syndrome (22q11.2DS) and report on, to our knowledge, the most comprehensive study undertaken to date in 22q11.2DS models. The study was conducted in male mice. Results: We found elevated postpubertal N-methyl-d-aspartate (NMDA) receptor antagonist–induced hyperlocomotion, age-independent prepulse inhibition (PPI) deficits and increased acoustic startle response (ASR). The PPI deficit and increased ASR were resistant to antipsychotic treatment. The PPI deficit was not a consequence of impaired hearing measured by auditory brain stem responses. The Df(h22q11)/+ mice also displayed increased amplitude of loudness-dependent auditory evoked potentials. Prefrontal cortex and dorsal striatal elevations of the dopamine metabolite DOPAC and increased dorsal striatal expression of the AMPA receptor subunit GluR1 was found. The Df(h22q11)/+ mice did not deviate from wild-type mice in a wide range of other behavioural and biochemical assays. Limitations: The 22q11.2 microdeletion has incomplete penetrance in humans, and the severity of disease depends on the complete genetic makeup in concert with environmental factors. In order to obtain more marked phenotypes reflecting the severe conditions related to 22q11.2DS it is suggested to expose the Df(h22q11)/+ mice to environmental stressors that may unmask latent psychopathology. Conclusion: The Df(h22q11)/+ model will be a valuable tool for increasing our understanding of the etiology of schizophrenia and other psychiatric disorders associated with the 22q11DS.",
author = "Michael Didriksen and Kim Fejgin and Nilsson, {Simon R O} and Birknow, {Michelle Rosgaard} and Grayton, {Hannah M.} and Larsen, {Peter H.} and Lauridsen, {Jes B.} and Vibeke Nielsen and Pau Celada and Noemi Santana and Pekka Kallunki and Christensen, {Kenneth V} and Werge, {Thomas M.} and Stensb{\o}l, {Tine B.} and Jan Egebjerg and Francois Gastambide and Francesc Artigas and Bastlund, {Jesper F.} and Jacob Nielsen",
year = "2017",
doi = "10.1503/jpn.150381",
language = "English",
volume = "42",
pages = "48--58",
journal = "Journal of Psychiatry and Neuroscience",
issn = "1180-4882",
publisher = "Canadian Medical Association",
number = "1",

}

RIS

TY - JOUR

T1 - Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome

T2 - A study in male mice

AU - Didriksen, Michael

AU - Fejgin, Kim

AU - Nilsson, Simon R O

AU - Birknow, Michelle Rosgaard

AU - Grayton, Hannah M.

AU - Larsen, Peter H.

AU - Lauridsen, Jes B.

AU - Nielsen, Vibeke

AU - Celada, Pau

AU - Santana, Noemi

AU - Kallunki, Pekka

AU - Christensen, Kenneth V

AU - Werge, Thomas M.

AU - Stensbøl, Tine B.

AU - Egebjerg, Jan

AU - Gastambide, Francois

AU - Artigas, Francesc

AU - Bastlund, Jesper F.

AU - Nielsen, Jacob

PY - 2017

Y1 - 2017

N2 - Background: The hemizygous 22q11.2 microdeletion is a common copy number variant in humans. The deletion confers high risk for neurodevelopmental disorders, including autism and schizophrenia. Up to 41% of deletion carriers experience psychotic symptoms. Methods: We present a new mouse model (Df(h22q11)/+) of the deletion syndrome (22q11.2DS) and report on, to our knowledge, the most comprehensive study undertaken to date in 22q11.2DS models. The study was conducted in male mice. Results: We found elevated postpubertal N-methyl-d-aspartate (NMDA) receptor antagonist–induced hyperlocomotion, age-independent prepulse inhibition (PPI) deficits and increased acoustic startle response (ASR). The PPI deficit and increased ASR were resistant to antipsychotic treatment. The PPI deficit was not a consequence of impaired hearing measured by auditory brain stem responses. The Df(h22q11)/+ mice also displayed increased amplitude of loudness-dependent auditory evoked potentials. Prefrontal cortex and dorsal striatal elevations of the dopamine metabolite DOPAC and increased dorsal striatal expression of the AMPA receptor subunit GluR1 was found. The Df(h22q11)/+ mice did not deviate from wild-type mice in a wide range of other behavioural and biochemical assays. Limitations: The 22q11.2 microdeletion has incomplete penetrance in humans, and the severity of disease depends on the complete genetic makeup in concert with environmental factors. In order to obtain more marked phenotypes reflecting the severe conditions related to 22q11.2DS it is suggested to expose the Df(h22q11)/+ mice to environmental stressors that may unmask latent psychopathology. Conclusion: The Df(h22q11)/+ model will be a valuable tool for increasing our understanding of the etiology of schizophrenia and other psychiatric disorders associated with the 22q11DS.

AB - Background: The hemizygous 22q11.2 microdeletion is a common copy number variant in humans. The deletion confers high risk for neurodevelopmental disorders, including autism and schizophrenia. Up to 41% of deletion carriers experience psychotic symptoms. Methods: We present a new mouse model (Df(h22q11)/+) of the deletion syndrome (22q11.2DS) and report on, to our knowledge, the most comprehensive study undertaken to date in 22q11.2DS models. The study was conducted in male mice. Results: We found elevated postpubertal N-methyl-d-aspartate (NMDA) receptor antagonist–induced hyperlocomotion, age-independent prepulse inhibition (PPI) deficits and increased acoustic startle response (ASR). The PPI deficit and increased ASR were resistant to antipsychotic treatment. The PPI deficit was not a consequence of impaired hearing measured by auditory brain stem responses. The Df(h22q11)/+ mice also displayed increased amplitude of loudness-dependent auditory evoked potentials. Prefrontal cortex and dorsal striatal elevations of the dopamine metabolite DOPAC and increased dorsal striatal expression of the AMPA receptor subunit GluR1 was found. The Df(h22q11)/+ mice did not deviate from wild-type mice in a wide range of other behavioural and biochemical assays. Limitations: The 22q11.2 microdeletion has incomplete penetrance in humans, and the severity of disease depends on the complete genetic makeup in concert with environmental factors. In order to obtain more marked phenotypes reflecting the severe conditions related to 22q11.2DS it is suggested to expose the Df(h22q11)/+ mice to environmental stressors that may unmask latent psychopathology. Conclusion: The Df(h22q11)/+ model will be a valuable tool for increasing our understanding of the etiology of schizophrenia and other psychiatric disorders associated with the 22q11DS.

U2 - 10.1503/jpn.150381

DO - 10.1503/jpn.150381

M3 - Journal article

AN - SCOPUS:85007108755

VL - 42

SP - 48

EP - 58

JO - Journal of Psychiatry and Neuroscience

JF - Journal of Psychiatry and Neuroscience

SN - 1180-4882

IS - 1

ER -

ID: 180736792